Takeda Pharmaceutical (TKPYY) shareholders, who are seeking to build support to block the $62B takeover of Shire (SHPG) , failed to get a proposal to require advance shareholder approval for large acquisitions passed at the company’s annual general meeting, Reuters reports, citing the company. The proposal garnered roughly 10% of votes in favor casting doubt on the group’s ability to get enough support to prevent the Shire deal.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.